Detalhe da pesquisa
1.
Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.
Blood
; 124(8): 1304-11, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24923295
2.
Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.
Blood
; 122(10): 1761-9, 2013 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23878140
3.
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
Blood
; 120(2): 395-403, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22649106
4.
Prognostic impact of CEBPA mutational subgroups in adult AML.
Leukemia
; 38(2): 281-290, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38228680
5.
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).
Leukemia
; 38(1): 45-57, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017103
6.
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.
Leukemia
; 37(6): 1234-1244, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041198
7.
RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.
Haematologica
; 97(12): 1909-15, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22689681
8.
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).
Ann Hematol
; 91(1): 9-18, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21744003
9.
NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS).
Blood
; 113(21): 5250-3, 2009 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19279329
10.
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia.
Leukemia
; 34(10): 2621-2634, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32358566
11.
Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA.
Blood Adv
; 2(20): 2724-2731, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30337300
12.
Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia.
PLoS One
; 9(3): e89560, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24608088
13.
Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis.
J Clin Oncol
; 32(4): 288-96, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24366930